Entity Details

Primary name SLC35C1
Entity type gene
Source Source Link

Details

PrimaryID55343
RefseqGeneNG_009875
SymbolSLC35C1
Namesolute carrier family 35 member C1
Chromosome11
Location11p11.2
TaxID9606
Statuslive
SourceGenomegenomic
SourceOriginnatural
CreationDate2001-05-09
ModificationDate2021-06-11

Ontological Relatives

UniProt IDsFUCT1_HUMAN

GO terms

Show/Hide Table
GOName
GO:0000139 Golgi membrane
GO:0005457 GDP-fucose transmembrane transporter activity
GO:0005794 Golgi apparatus
GO:0008643 carbohydrate transport
GO:0015297 antiporter activity
GO:0016021 integral component of membrane
GO:0030259 lipid glycosylation
GO:0036066 protein O-linked fucosylation
GO:0036085 GDP-fucose import into Golgi lumen
GO:0045746 negative regulation of Notch signaling pathway

Diseases

Show/Hide Table
Disease IDSourceNameDescription
266265 OMIMCongenital disorder of glycosylation 2C (CDG2C)A multisystem disorder caused by a defect in glycoprotein biosynthesis and characterized by under-glycosylated serum glycoproteins. Congenital disorders of glycosylation result in a wide variety of clinical features, such as defects in the nervous system development, psychomotor retardation, dysmorphic features, hypotonia, coagulation disorders, and immunodeficiency. The broad spectrum of features reflects the critical role of N-glycoproteins during embryonic development, differentiation, and maintenance of cell functions. The clinical features of CDG2C include mental retardation, short stature, facial stigmata, and recurrent bacterial peripheral infections with persistently elevated peripheral leukocytes. Biochemically, CDG2C is characterized by a lack of fucosylated glycoconjugates, including selectin ligands. The disease is caused by variants affecting the gene represented in this entry.

Interactions

4 interactions

InteractorPartnerSourcesPublicationsLink
SLC35C1APODBioGRID, IntAct28514442 details
SLC35C1TMX1BioGRID, IntAct30021884 details
SLC35C1ARMC8BioGRID29911972 details
SLC35C1DDX58BioGRID32513696 details